Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ran Moriguchi"'
Autor:
Mizuki, Aimoto, Takahisa, Yamane, Mitsuru, Ichii, Katsuhito, Mori, Ran, Moriguchi-Aimoto, Eri, Wada-Inoue, Hideo, Koh, Takahiko, Nakane, Yasunobu, Takeoka, Mika, Akahori-Nakamae, Saori, Nishiki-Kosaka, Yoshiki, Terada, Hirohisa, Nakamae, Ki-Ryang, Koh, Takafumi, Nakao, Masahiko, Ohsawa, Kenichi, Wakasa, Eiji, Ishimura, Masaaki, Inaba, Masayuki, Hino
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 52(7)
A 38-year-old man was diagnosed with acute lymphoblastic leukemia. We performed myeloablative bone marrow transplantation from an unrelated donor during the patient's first complete remission. After engraftment, he developed acute graft-versus-host d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2509a47226af944142811a9fa034fb59
https://pubmed.ncbi.nlm.nih.gov/21821990
https://pubmed.ncbi.nlm.nih.gov/21821990
Autor:
Mizuki, Aimoto, Takahisa, Yamane, Atushi, Inoue, Dai, Momose, Ran, Moriguchi-Aimoto, Eri, Wada-Inoue, Syuuichirou, Okamoto, Hideo, Koh, Takahiko, Nakane, Yasunobu, Takeoka, Mika, Akahori-Nakamae, Saori, Nishiki-Kosaka, Yoshiki, Terada, Hirohisa, Nakamae, Ki-Ryang, Koh, Takafumi, Nakao, Masahiko, Ohsawa, Masayuki, Hino
Publikováno v:
[Rinsho ketsueki] The Japanese journal of clinical hematology. 51(12)
A 64-year-old man was diagnosed as having acute myeloid leukemia. We performed sequential treatment with chemotherapy and reduced-intensity stem cell transplantation from an unrelated donor while the patient was in partial remission. After engraftmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d3f6a1d7119db9e09d22bde20ac3e756
https://pubmed.ncbi.nlm.nih.gov/21258188
https://pubmed.ncbi.nlm.nih.gov/21258188
Autor:
Kensuke Ohta, Hirofumi Teshima, Hideo Koh, Takahisa Yamane, Ki Ryang Koh, Ran Moriguchi, Shuichirou Okamoto, Masayuki Hino, Dai Momose, Hiroshi Kanashima, Hirohisa Nakamae, Atsuko Mugitani, Yoshiki Terada, Yasunobu Takeoka, Takahiko Nakane, Mizuki Aimoto, Erina Sakamoto, Eri Wada, Yoshitaka Nakao
Publikováno v:
Blood. 112:4931-4931
Background. Recently several retrospective studies showed that relative dose intensity (RDI) in combination chemotherapy including CHOP significantly influences survival in aggressive lymphoma. Based on these data, maintaining high RDI in chemotherap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9ca95bd41ab4969706de76733f46d46
https://doi.org/10.1182/blood.v112.11.4931.4931
https://doi.org/10.1182/blood.v112.11.4931.4931
Autor:
Mizuki Aimoto, Kensuke Ohta, Hideo Koh, Eri Wada, Hirohisa Nakamae, Erina Sakamoto, Yoshiki Terada, Masayuki Hino, Hirofumi Teshima, Yuki Akazawa, Takahiko Nakane, Ki-Ryang Koh, Ran Moriguchi, Yoshitaka Nakao, Hiroshi Kanashima, Yasunobu Takeoka, Takahisa Yamane
Publikováno v:
Blood. 110:4456-4456
Introduction: The achievement of a clinical response to the first induction chemotherapy has been considered for predicting survival in patients (pts) with aggressive non-Hodgkin lymphoma (NHL). Reduced dose intensity of chemotherapy has been likely
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1885b54c6a51bf64fad6cc58462bc196
https://doi.org/10.1182/blood.v110.11.4456.4456
https://doi.org/10.1182/blood.v110.11.4456.4456